Lista de obras -

1055Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12.

artículo científico publicado en 2014

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

artículo científico

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States

artículo científico publicado en 2018

2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018

2568. Variability in Pediatric Antibiotic Prescribing for Upper Respiratory Illnesses by Provider Specialty

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink

535Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network.

artículo científico publicado en 2014

650Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network.

artículo científico publicado en 2014

77. Antimicrobial Prescribing Practices for Enteric Bacterial Infections in an Integrated Rural Healthcare System, 2004–2017

900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018

991. Randomized Trial of High Dose, Adjuvanted, and Standard Inactivated Influenza Vaccine Immune Response Against Egg- and Cell-Propagated Vaccine Strains in Older Adults, 2016–2017 Season

Adverse Events among Young Adults following a Third Dose of Measles-Mumps-Rubella Vaccine

artículo científico publicado en 2020

An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children

artículo científico publicado en 2017

Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15

scientific article published on 18 November 2019

Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.

artículo científico publicado en 2018

Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.

artículo científico publicado en 2017

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents

artículo científico publicado en 2017

Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine

scientific article published on 05 October 2018

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons

artículo científico publicado en 2017

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients

artículo científico publicado en 2016

Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018

artículo científico publicado en 2020

Determinants of human papillomavirus vaccine attitudes: an interview of Wisconsin parents.

artículo científico publicado en 2018

Earliest infections predict the age distribution of seasonal influenza A cases

scientific article published on 07 July 2020

Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

artículo científico publicado en 2015

Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016

artículo científico publicado en 2019

Effect of Statin Use on Influenza Vaccine Effectiveness

artículo científico publicado en 2016

Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020

scientific article published on 25 December 2020

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017

scientific article published on 01 February 2020

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States

artículo científico publicado en 2015

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season

artículo científico

Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18

scientific article published on 07 June 2020

Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience

artículo científico

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

artículo científico publicado en 2016

Hospital Discharge Data Underascertain Enteric Bacterial Infections Among Children

artículo científico publicado en 2020

Hospitalisations due to bacterial gastroenteritis: A comparison of surveillance and hospital discharge data.

artículo científico publicado en 2018

Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16

artículo científico publicado en 2018

Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children

scientific article published on 22 October 2020

Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial

artículo científico publicado en 2015

Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak

artículo científico publicado en 2012

Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons

artículo científico publicado en 2014

Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020

artículo científico publicado en 2021

Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention.

artículo científico publicado en 2017

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States

artículo científico publicado en 2018

Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016.

artículo científico publicado en 2018

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

artículo científico publicado en 2016

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016.

artículo científico publicado en 2017

Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017

scientific article published on 01 May 2019

Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses

artículo científico publicado en 2015

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season.

artículo científico publicado en 2017

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season

artículo científico publicado en 2017

Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season

artículo científico publicado en 2019

Influenza Vaccine Effectiveness: Defining the H3N2 Problem

artículo científico publicado en 2019

Influenza Vaccine Effectiveness: New Insights and Challenges

scientific article published on 27 January 2020

Influenza and Workplace Productivity Loss in Working Adults.

artículo científico publicado en 2017

Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness

artículo científico publicado en 2013

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016

artículo científico publicado en 2018

Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018

scientific article published on 09 April 2020

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

artículo científico publicado en 2018

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

artículo científico publicado en 2014

Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.

artículo científico publicado en 2017

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

artículo científico publicado en 2018

Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019

article

Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020

artículo científico publicado en 2020

Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

artículo científico publicado en 2014

Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018

article

Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness.

artículo científico publicado en 2012

Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine

artículo científico publicado en 2018

Mumps Virus Nucleoprotein and Hemagglutinin-Specific Antibody Response Following a Third Dose of Measles Mumps Rubella Vaccine

artículo científico publicado en 2017

Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age

artículo científico publicado en 2020

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons

Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness

scientific article published on 04 May 2020

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

artículo científico publicado en 2013

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States

artículo científico publicado en 2017

Protecting Young Infants From Measles

scientific article published on 01 December 2019

Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination

scientific article published on 23 April 2020

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19

scientific article published on 12 August 2020

Repeated annual influenza vaccination and vaccine effectiveness: review of evidence

artículo científico publicado en 2017

Risk factors for transmission of mumps in a highly vaccinated population in Orange County, NY, 2009-2010.

artículo científico publicado en 2014

Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults

artículo científico publicado en 2018

School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015.

artículo científico publicado en 2016

Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine

artículo científico publicado en 2016

Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018

artículo científico publicado en 2020

Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010.

artículo científico publicado en 2015

Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.

artículo científico publicado en 2018

Sociodemographic and clinical correlates of human papillomavirus vaccine attitudes and receipt among Wisconsin adolescents

artículo científico publicado en 2019

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season

artículo científico publicado en 2020

The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety Datalink

artículo científico publicado en 2019

The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety Datalink

scientific article published on 03 December 2019

Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020

artículo científico publicado en 2020

Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season

artículo científico publicado en 2014

Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season

artículo científico publicado en 2015

Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season

artículo científico publicado en 2018

Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project

article

Validation of self-reported influenza vaccination in the current and prior season

scientific article published on 14 August 2018

Variability in Antibiotic Prescribing for Upper Respiratory Illnesses by Provider Specialty

scientific article published on 05 September 2018

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

artículo científico publicado en 2016

Lista de obras de

1055Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12.

2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States

2062. Improving Antibiotic Prescribing in the Ambulatory Care Setting—Stewardship through Influenza Vaccination, US Flu VE Network 2013–2014 Through 2017–2018

2568. Variability in Pediatric Antibiotic Prescribing for Upper Respiratory Illnesses by Provider Specialty

2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018

2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink

535Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network.

650Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network.

77. Antimicrobial Prescribing Practices for Enteric Bacterial Infections in an Integrated Rural Healthcare System, 2004–2017

900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018

988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018

991. Randomized Trial of High Dose, Adjuvanted, and Standard Inactivated Influenza Vaccine Immune Response Against Egg- and Cell-Propagated Vaccine Strains in Older Adults, 2016–2017 Season

Adverse Events among Young Adults following a Third Dose of Measles-Mumps-Rubella Vaccine

An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children

Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15

Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.

Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents

Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons

Classification and Regression Tree (CART) analysis to predict influenza in primary care patients

Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018

Determinants of human papillomavirus vaccine attitudes: an interview of Wisconsin parents.

Earliest infections predict the age distribution of seasonal influenza A cases

Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016

Effect of Statin Use on Influenza Vaccine Effectiveness

Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States

Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season

Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18

Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

Hospital Discharge Data Underascertain Enteric Bacterial Infections Among Children

Hospitalisations due to bacterial gastroenteritis: A comparison of surveillance and hospital discharge data.

Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16

Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children

Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial

Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak

Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons

Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020

Improving Human Papillomavirus Vaccine Use in an Integrated Health System: Impact of a Provider and Staff Intervention.

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States

Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016.

Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016.

Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017

Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011-2012 and 2012-2013: The Importance of Two Priming Doses

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season.

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season

Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season

Influenza Vaccine Effectiveness: Defining the H3N2 Problem

Influenza Vaccine Effectiveness: New Insights and Challenges

Influenza and Workplace Productivity Loss in Working Adults.

Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness

Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016

Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type

Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017.

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019

Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020

Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014.

Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018

Measles outbreak in Burkina Faso, 2009: a case-control study to determine risk factors and estimate vaccine effectiveness.

Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine

Mumps Virus Nucleoprotein and Hemagglutinin-Specific Antibody Response Following a Third Dose of Measles Mumps Rubella Vaccine

Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons

Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States

Protecting Young Infants From Measles

Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination

Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19